Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Comparative Effectiveness Research|July 19, 2021
The use of nonrandomized evidence to estimate treatment effects in health technology assessmentSeamus Kent, Maximilian Salcher-Konrad, Stefania Boccia, et al.CNS Drugs|November 24, 2018
Regulatory and Health Technology Assessment Considerations for Disease-Modifying Drugs in Alzheimer's DiseaseJacoline C Bouvy, Pall Jonsson, Diana O'Rourke, et al.BMJ Open|October 17, 2022
Using primary care data to assess comparative effectiveness and safety of apixaban and rivaroxaban in patients with nonvalvular atrial fibrillation in the UK: an observational cohort studyAshley Jaksa, Liza Gibbs, Seamus Kent, et al.Plos One|October 14, 2016
A Study on the Basic Criteria for Selecting Heterogeneity Parameters of F18-FDG PET ImagesAttila Forgacs, Hermann Pall Jonsson, Magnus Dahlbom, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 8, 2023
Perspectives on Patient-Reported Outcome Data After Treatment Discontinuation in Cancer Clinical TrialsBellinda L King-Kallimanis, Melanie Calvert, David Cella, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 17, 2020
Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing-Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency InitiativeLucinda S Orsini, Marc Berger, William Crown, et al.Pharmacoepidemiology and Drug Safety|September 14, 2020
Improving transparency to build trust in real-world secondary data studies for hypothesis testing-Why, what, and how: recommendations and a road map from the real-world evidence transparency initiativeLucinda S Orsini, Brigitta Monz, C Daniel Mullins, et al.Journal of Alzheimer'S Disease : JAD|December 26, 2018
Challenges for Optimizing Real-World Evidence in Alzheimer's Disease: The ROADMAP ProjectJohn Gallacher, Frederic de Reydet de Vulpillieres, Billy Amzal, et al.Pageof 2